Becton Dickinson and Company (BDX) , popularly known as BD, is scheduled to report second-quarter fiscal 2025 results on May 1, before market open.In the last reported quarter, the company’s earnings per share (EPS) of $3.43 surpassed the Zacks Consensus Estimate by 15.1%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 7.3%, on average. (See the Zacks Earnings Calendar to stay ahead of market-making news.)Let’s che ...

Phasix™ ST Umbilical Hernia Patch Leverages Same Surgical Technique as Permanent Mesh Procedures FRANKLIN LAKES, N.J., April 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the commercial launch of Phasix™ ST Umbilical Hernia Patch, the first and only fully absorbable hernia patch on the market designed specifically for umbilical hernias.   BD launche ...

Becton, Dickinson and Company (BDX) , popularly known as BD, launched a new advanced hemodynamic monitoring platform, HemoSphere Alta, yesterday. The platform is equipped with predictive, artificial intelligence (AI)-based algorithms that will likely aid clinicians to address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.The HemoSphere Alta platform, which is BD's most advanced hemodynamic monitoring technology currently available, i ...

HemoSphere Alta™ Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical SituationsFRANKLIN LAKES, N.J., April 21, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (AI) based algorithms that can help clinicians proactively address blood pressure insta ...

I've been investing in stocks since 2005 and writing about this portfolio since 2013. During those twenty years, I've learned many things, but none more important than the realization that I cannot time the market.Website: www.DGIfortheDIY.comA Civil Engineer, who is married with four young kids. In early 2013 I took a more active role in managing my IRA for retirement and decided to publicly share my experiences in building the portfolio. My hope is to provide a positive example for other young do-it-yours ...

Becton, Dickinson and Company (BDX) , popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company. According to a Financial Times report, BD has initiated discussions with several potential buyers, including Thermo Fisher Scientific, Danaher and a group of smaller diagnostics companies. This move follows BD’s February announcement that it would explore strategic alternatives for the unit, including a full ...

FRANKLIN LAKES, N.J., April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to discuss the Company's financial results for its second quarter of fiscal year 2025, which ended on March 31, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors ...

FRANKLIN LAKES, N.J., March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture. "As one of the largest manufacturers of medical devices in the world whose products ...

文章核心观点 - 全球领先医疗技术公司BD于2025年3月26日任命Gregory J. Hayes为董事会成员 [1] 任命情况 - 64岁的Gregory J. Hayes现任全球最大航空航天和国防公司RTX Corporation董事会执行主席 拥有超30年高管经验 曾担任CEO和高级领导职务 涉及财务、企业战略和业务发展等职能 [2] - 他的任命符合公司对强大公司治理和定期董事会更新的持续承诺 自2021年以来 BD董事会已新增四名新的独立董事 [2] 公司评价 - BD董事长、CEO兼总裁Tom Polen表示 Greg将在BD转型的关键时刻加入董事会 其在投资组合优化、战略卓越和提高运营效率方面的良好记录与BD卓越操作系统和持续改进文化相契合 他将是董事会和BD未来成功的宝贵资产 [3] 被任命者观点 - Gregory J. Hayes称BD作为领先医疗设备制造商有125年卓越历史 对医疗保健系统基础设施至关重要 期待利用自身经验帮助监督成功分拆 并将“新BD”打造成差异化、专注的纯医疗科技公司 以加速创新、推动盈利增长并为所有利益相关者带来长期可持续价值 [4] 被任命者履历 - 在被任命为RTX董事会成员之前 Hayes在联合技术公司（UTC）工作了二十年 2014年被任命为CEO 2016年担任董事长 他促成了RTX的成立 还曾于2008 - 2014年担任UTC首席财务官 他还担任菲利普斯66公司董事会成员 [3] 公司介绍 - BD是全球最大的医疗技术公司之一 通过改善医学发现、诊断和医疗服务推动全球健康发展 公司拥有超7万名员工 业务几乎覆盖全球各国 与世界各地组织合作应对全球健康挑战 [5]

文章核心观点 - 百特医疗（BD）因输液泵软件问题发起召回，被FDA列为一级召回，虽暂无伤亡报告但继续使用或致严重后果，该事件或影响公司销售，行业也面临输液泵软件可靠性挑战 [1][4][5] 召回情况 - 召回产品为BD Alaris Systems Manager和BD Care Coordination Engine (CCE) Infusion Adapter [2][8] - 召回原因是软件问题，包括系统响应延迟和自动编程请求积压，可能导致治疗给药错误 [5] - 去年8月百特召回近2.3万台设备，今年5月OptumHealth召回208台泵，8月史密斯医疗进行医疗器械纠正，均因软件问题 [9] 公司股价表现 - 自上周一级召回分类以来，BDX股价下跌0.9%，今年以来公司股价上涨0.5%，行业增长1.7%，同期标准普尔500指数下跌2.7% [3] 公司业务背景 - 2015年公司收购CareFusion 303将Alaris泵纳入产品组合，2023年前按同意令销售，2023年获FDA 510(k)批准更新系统，2024年该泵重新推出使营收增长近50个基点 [4] 行业市场规模 - 2023年全球输液泵市场价值26亿美元，预计到2033年将增长至33亿美元 [10] 公司评级与推荐 - BD目前Zacks排名为3（持有） [11] - 医疗领域排名较好的股票有卡地纳健康（CAH）、Cencora（COR）和波士顿科学（BSX），均为Zacks排名2（买入） [11][12][13] - 卡地纳健康预计长期增长率9.5%，过去四个季度盈利超预期，平均惊喜率9.6%，今年以来股价上涨12.2% [12] - Cencora预计长期增长率12.1%，过去四个季度盈利超预期，平均惊喜率4.9%，年初至今股价上涨19.5% [13] - 波士顿科学预计长期增长率13.3%，过去四个季度盈利超预期，平均惊喜率8.3%，今年以来股价上涨15.4% [13][14]